Directors had approved the appointment Mr. Sophon Permsirivallop, C.P.A. Registration No. 3182, and/or Ms. Rungnapa Lertsuwankul, C.P.A. Registration No. 3516, and/or Ms. Pimjai Manitkajohnkit, C.P.A
of the total issued shares of the Company and indirectly hold 18.97 percent of the total issued shares of the Company through GSTEL (after registration of the Company’s paid-up capital)1, will nominate
Directors had approved the appointment Mr. Sophon Permsirivallop, C.P.A. Registration No. 3182, and/or Ms. Rungnapa Lertsuwankul, C.P.A. Registration No. 3516, and/or Ms. Pimjai Manitkajohnkit, C.P.A
structured notes to be offered for sale with the SEC and has a statement in the certificate that the issuer shall not accept transfer registration of structured notes that is inconsistent with a transfer
- commissioning activities planned in December 2017 and startup early 2018. In addition to improved cash flows as a result of the better performance, the Company’s Balance Sheet al- so strengthened as a consequence
sheet and cash flow generation are strong, allowing us to invest significantly in our growth engines, through selective growth and turnaround opportunities, leveraging our strengths in core markets and in
earnings. IVL balance sheet and cash flow generation are strong, allowing us to invest significantly in our growth engines, through selective growth and turnaround opportunities, leveraging our strengths in
, diversified and steady cash flows making it a unique world-class chemical company. This acquisition will be funded by cash and debt and there is no equity dilution anticipated. IVL balance sheet was
continued to outperform Core EPS of THB 3.86, delivering earnings growth for the 18th consecutive quarter Operating Cash Flow of $923 million, helps strengthen balance sheet and fund future growth
announced our joint support for chemical recycling of PET waste in the Netherlands which is expected in 4Q19. Stronger Balance Sheet with Prudent Growth IVL business model has evolved over the years with